Hedna Khedidja, Andersson Sundell Karolina, Hamidi Armina, Skoog Ingmar, Gustavsson Sara, Waern Margda
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE-413 45, Gothenburg, Sweden.
Section of Epidemiology and Social Medicine, Department of Public Health and Community Medicine at Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
Eur J Clin Pharmacol. 2018 Feb;74(2):201-208. doi: 10.1007/s00228-017-2360-x. Epub 2017 Nov 4.
To investigate associations between antidepressant use patterns and risk of fatal and non-fatal suicidal behaviours in older adults who initiated antidepressant therapy.
A national population-based cohort study conducted among Swedish residents aged ≥ 75 years who initiated antidepressant treatment. Patients who filled antidepressant prescriptions between January 1, 2007 and December 31, 2013 (N = 185,225) were followed until December 31, 2014. Sub-hazard ratios of suicides and suicide attempts associated with use patterns of antidepressants, adjusting for potential confounders such as serious depression were calculated using the Fine and Gray regression models.
During follow-up, 295 suicides and 654 suicide attempts occurred. Adjusted sub-hazard ratios (aSHRs) were increased for both outcomes in those who switched to another antidepressant (aSHR for suicide 2.42, 95% confidence interval 1.65 to 3.55, and for attempt 1.76, 1.32 to 2.34). Elevated suicide risks were also observed in those who concomitantly filled anxiolytics (1.54, 1.20 to 1.96) and hypnotics (2.20, 1.69 to 2.85). Similar patterns were observed for the outcome suicide attempt. Decreased risk of attempt was observed among those with concomitant use of anti-dementia drugs (0.40, 0.27 to 0.59).
Switching antidepressants, as well as concomitant use of anxiolytics or hypnotics, may constitute markers of increased risk of suicidal behaviours in those who initiate antidepressant treatment in very late life. Future research should consider indication biases and the clinical characteristics of patients initiating antidepressant therapy.
探讨开始抗抑郁治疗的老年人中抗抑郁药物使用模式与致命和非致命自杀行为风险之间的关联。
在瑞典≥75岁开始抗抑郁治疗的居民中进行一项基于全国人口的队列研究。对2007年1月1日至2013年12月31日期间开具抗抑郁药物处方的患者(N = 185,225)进行随访,直至2014年12月31日。使用Fine和Gray回归模型计算与抗抑郁药物使用模式相关的自杀和自杀未遂的亚风险比,并对严重抑郁症等潜在混杂因素进行调整。
随访期间,发生了295例自杀和654例自杀未遂。改用另一种抗抑郁药物的患者,这两种结局的调整后亚风险比(aSHRs)均升高(自杀的aSHR为2.42,95%置信区间为1.65至3.55,自杀未遂的aSHR为1.76,1.32至2.34)。同时开具抗焦虑药(1.54,1.20至1.96)和催眠药(2.20,1.69至2.85)的患者自杀风险也升高。自杀未遂结局观察到类似模式。同时使用抗痴呆药物的患者自杀未遂风险降低(0.40,0.27至0.59)。
在高龄开始抗抑郁治疗的患者中,更换抗抑郁药物以及同时使用抗焦虑药或催眠药可能是自杀行为风险增加的标志。未来研究应考虑指征偏倚以及开始抗抑郁治疗患者的临床特征。